MindChild Medical, Inc. Announces Fetal QT Study Publication

(BusinessWire, North Andover, Massachusetts), MindChild Medical, Inc. today announced publication of "Evaluation of the fetal QT interval using non-invasive fetal ECG technology" in the Journal of Physiological Measurement.1 The evaluation was conducted by investigators at Technion-IIT, University of Oxford, Tufts Medical Center, Boston Children’s Hospital, Seattle Children’s Hospital, Brigham and Women’s Hospital, MindChild Medical, Emory University and Georgia Institute of Technology. Utilizing MERIDIAN non-invasive fetal electrocardiography (NI-FECG) technology enables accurate extraction of the fetal QT interval. According to senior author, Gari D. Clifford, PhD2,3 , “These results provide evidence that non-invasive fetal electrocardiography (NI-FECG) technology enables accurate extraction of the fetal QT interval.” Dr. Clifford continued, “Fetal QT interval changes are critical in managing fetal health. The ability to extract high quality fetal QT intervals may have profound diagnostic implications and provide insight to proactive fetal management.” Long QT syndrome (LQTS) has been shown to be a major determinant in young sudden death individuals for which an autopsy was performed but had remained inconclusive4 and a determinant for as much as 10% of sudden infant death syndrome (SIDS).5,